Breast cancer is the most common type diagnosed in women. It originates in the cells of the mammary epithelium and can occur in both men and women; however, it is much more common in women. Globally, in proportion, it is estimated that breast cancer affects one man for every 100 women. Despite the lower incidence in men, the diagnosis is usually made later than in women due to ignorance and lack of suspicion regarding the symptoms. Awareness, visibility and support must be extended to all those affected. The fight against breast cancer does not distinguish gender.
At the initiative of the World Health Organization, October 19 is celebrated worldwide as the International Day to Fight Breast Cancer with the aim of raising awareness and promoting more and more women access to timely and effective controls, diagnoses and treatments.
Within CENL, different people do research in this area. For example, Dr. Ana Ruiz-Saenz states that: “breast cancer has a high incidence in society. It is estimated that one in eight women will develop breast cancer during their lifetime. Fortunately, scientific advances have allowed the development of treatments that have changed the lives of these patients. But there’s still a lot to do. A high number of patients will develop resistance to treatment. Therefore, it is key that we continue working and advancing in all areas, from prevention, early diagnosis and the development of new drugs to ensure that one day we can celebrate this day as the international day of victory against breast cancer”.
Can you help us to become more? Become a member and participate. Spread our word on the networks. Contact us and tell us about yourself and your project.
Aitor Tejo Otero
Postdoc en la Univesidad de Utrecht
Doctor en Ingeniería Mecánica por la Universidad Politécnica de Catalunya (UPC) en el año 2021. Se especializó en el campo de la fabricación aditiva aplicado al sector médico. A día de hoy, se encuentra realizando sus postdoctorado en la Universidad de Utrecht en el campo de la biofabricación. Sus intereses son la ciencia, el teatro y la divulgación.
Ana Ruiz-Saenz
Assistant Professor at the Erasmus University Medical Center
Soy doctora en Biología Molecular por la Universidad Autónoma de Madrid. Realicé mi etapa postdoctoral en la Universidad de California San Francisco y actualmente dirijo mi grupo de investigación en el Erasmus University Medical Center en Rotterdam. Nuestro trabajo se centra en entender los mecanismos moleculares que dirigen la respuesta y la resistencia a terapias contra el cáncer. Una de las líneas de investigación más importantes que estamos desarrollando en este momento está orientada hacia el impacto de la glicosilación de las células tumorales (la capa de azúcares que las recubre) en la eficacia de terapias dirigidas en cáncer de mama.
Crecí entre Arnedo y Herce, en La Rioja, a donde vuelvo siempre que puedo. Me gusta disfrutar de los amigos, viajar y tocar al piano nocturnos de Chopin cuando llueve.
